MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.01926-2025

Медицинская библиотека · The European respiratory journal · 2026

Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement.

Fally Markus, Cilloniz Catia, Linnell John, Aliberti Stefano, Barac Aleksandra, Blasi Francesco, Cumber Alan, Dilorenzo Phyliss, Dimopoulos George, Gainer Caroline, van Geffen Wouter H, Gramegna Andrea, Hoehn Barry, Polverino Eva, Roger Claire, Rovina Nikoletta, Stolz Daiana, Waterer Grant, Williams Clare, Wootton Dan, Mathioudakis Alexander G, Felton Timothy W

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Clinical trials assessing the management of pneumonia use heterogeneous outcomes, often lacking patient relevance or standardisation. We developed two core outcome sets (COSs) for future clinical trials evaluating interventions in community-acquired pneumonia (CAP) and nosocomial pneumonia (hospital-acquired pneumonia and ventilator-associated pneumonia) to improve the consistency and comparability of evidence.

METHODS

A multistage, multistakeholder process was undertaken, comprising 1) a systematic review of previously used outcomes conducted by our team, 2) qualitative interviews with patients and 3) a two-round online Delphi survey involving 289 participants (patients, relatives and healthcare professionals) from 58 countries. This diverse sample ensured a broad representation of clinical and patient perspectives. Final outcomes were agreed upon through structured voting in two virtual consensus meetings in April 2025.

RESULTS

The final COS for CAP includes: treatment success/failure, all-cause mortality, serious adverse events, readmissions (admission for community-based trials), duration of symptoms and time to clinical stability (for hospitalised patients). The nosocomial pneumonia COS includes: treatment success/failure, all-cause mortality, serious adverse events, readmission and need for ventilatory support. The panel suggested measuring mortality at 30 days from study enrolment and readmission at 30 days post-discharge.

CONCLUSIONS

These COSs, developed by a European Respiratory Society Task Force, provide a standardised framework for outcome selection in pneumonia trials and were informed by broad stakeholder input, including patients. Their use is expected to improve the relevance, quality and comparability of future research in pneumonia.

Для цитирования: Fally Markus, Cilloniz Catia, Linnell John, Aliberti Stefano, Barac Aleksandra, Blasi Francesco, Cumber Alan, Dilorenzo Phyliss, Dimopoulos George, Gainer Caroline, van Geffen Wouter H, Gramegna Andrea, Hoehn Barry, Polverino Eva, Roger Claire, Rovina Nikoletta, Stolz Daiana, Waterer Grant, Williams Clare, Wootton Dan, Mathioudakis Alexander G, Felton Timothy W. Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement.. The European respiratory journal. 2026. DOI: 10.1183/13993003.01926-2025.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.